Back to News
Market Impact: 0.2
Windtree Therapeutics Average Price Target Increased by 97.74% to $357.00
Source: Nasdaq
Analyst EstimatesAnalyst Insights
Windtree Therapeutics' average one-year analyst price target was revised to $357.00 per share, up 97.74% from the prior $180.54 estimate dated June 18, 2025. The figures are aggregate analyst targets compiled from multiple sources; the article provides no share-price reaction or supporting rationale.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
More News
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Reliance’s Record $19 Billion Surge Lifts Nifty, Keeps India Bulls in the Game
- Apple reports after the bell. Options traders expect a big move
- Mizuho lowers Lumentum stock price target on Marvell acquisition
- Why is Apple stock falling afterhours today?
- RA Capital Management sells $9.13M in Lenz Therapeutics shares